Pain management in hospitals: patients’ satisfaction and related barriers S Tawil, K Iskandar, P Salameh Pharmacy Practice (Granada) 16 (3), 2018 | 35 | 2018 |
Mandatory continuing education for pharmacists in a developing country: assessment of a three-year cycle H Sacre, S Tawil, S Hallit, G Sili, P Salameh Pharmacy Practice (Granada) 17 (3), 2019 | 29 | 2019 |
Attitudes of Lebanese pharmacists towards online and live continuing education sessions H Sacre, S Tawil, S Hallit, A Hajj, G Sili, P Salameh Pharmacy Practice (Granada) 17 (2), 2019 | 17 | 2019 |
Assessment of knowledge, attitude, and practice regarding the disposal of expired and unused medications among the Lebanese population A Hajj, S Domiati, C Haddad, H Sacre, M Akl, M Akel, S Tawil, S Abramian, ... Journal of Pharmaceutical Policy and Practice 15 (1), 107, 2022 | 9 | 2022 |
The Arabic urticaria activity score and chronic urticaria quality of life questionnaire: validation and correlations S Tawil, C Irani, R Kfoury, P Salameh, I Baiardini, K Weller, M Maurer, ... International Journal of Dermatology 59 (8), 893-901, 2020 | 8 | 2020 |
Lebanese pharmacists’ confidence and self-perceptions of computer literacy: scale validation and correlates S Hallit, S Tawil, H Sacre, C Rahme, A Hajj, P Salameh Journal of Pharmaceutical Policy and Practice 13, 1-8, 2020 | 7 | 2020 |
Patients’ perceptions regarding pharmacists’ healthcare services: the case of Lebanon S Tawil, H Sacre, G Sili, P Salameh Journal of Pharmacy Practice and Research 50 (2), 137-143, 2020 | 7 | 2020 |
Pharmacists and continuing education: a cross-sectional observational study of value and motivation S Tawil, S Hallit, H Sacre, A Hajj, P Salameh International Journal of Pharmacy Practice 28 (4), 380-389, 2020 | 6 | 2020 |
Enoxaparin 20 mg for thromboprophylaxis in severe renal impairment LR Karaoui, S Tawil, P Salameh, N Chamoun Journal of International Medical Research 47 (1), 225-234, 2019 | 6 | 2019 |
The specialized competency framework for community pharmacists (SCF-CP) in Lebanon: validation and evaluation of the revised version F Sakr, M Akel, H Sacre, C Haddad, S Tawil, J Safwan, A Hajj, RM Zeenny, ... Journal of Pharmaceutical Policy and Practice 16 (1), 77, 2023 | 5 | 2023 |
Association of chronic urticaria with psychological distress: a multicentre cross-sectional study S Tawil, C Irani, R Kfoury, S Abramian, P Salameh, K Weller, M Maurer, ... Acta Dermato-Venereologica 103, 2023 | 5 | 2023 |
Navigating the crisis: A review of COVID-19 research and the importance of academic publications-The case of a private university in Lebanon N Khaddage-Soboh, S Tawil Heliyon, 2023 | | 2023 |
Mental health during COVID-19: an evaluation of an academic university’s contribution to existing research S Tawil, P Salameh | | 2023 |
Mental health during COVID-19: an evaluation of an academic university’s contribution to existing research (preprint) S Tawil, P Salameh | | 2023 |
Maladies causées par les mastocytes (MCDD): Epidémiologie clinique et prise en charge dans la région du Moyen-Orient S Tawil | | 2021 |
Mast cell Driven Diseases (MCDD): clinical epidemiology and management aspects in a Middle Eastern country S Al Tawil Université Paris-Est, 2021 | | 2021 |
Évaluation de l’urticaire à l’aide d’un outil de diagnostic autodéclaré (SRUD): une étude de validation multicentrique S Al Tawil, C Irani, R Kfoury, S Abramian, P Salameh, K Weller, M Maurer, ... Annales de Dermatologie et de Vénéréologie-FMC 1 (8), A223, 2021 | | 2021 |
Les versions arabes du score d’activité de l’urticaire et le questionnaire sur la qualité de vie de l’urticaire chronique: validation et corrélation S Al Tawil, C Irani, R Kfoury, P Salameh, I Baiardini, K Weller, M Maurer, ... Annales de Dermatologie et de Vénéréologie-FMC 1 (8), A225-A226, 2021 | | 2021 |
Assessment of urticaria using a self‐reported diagnosis tool (SRUD): a multicentre validation study. S Tawil, C Irani, R Kfoury, S Abramian, P Salameh, K Weller, M Maurer, ... Journal of the European Academy of Dermatology & Venereology 35 (10), 2021 | | 2021 |
801: EFFICACY AND SAFETY OF ENOXAPARIN 20 MG SUBCUTANEOUSLY IN PATIENTS WITH CHRONIC KIDNEY DISEASE STAGES 4 AND 5 FOR DEEP VEIN THROMBOSIS PROPHYLAXIS L Karaoui, S Tawil Critical Care Medicine 39 (12), 225, 2011 | | 2011 |